Parkinson’s disease is a neurological condition that affects over 10 million people worldwide, causing movement and balance issues. While there is no cure for Parkinson’s, deep brain stimulation (DBS) has been developed as a surgical treatment to alleviate symptoms. However, some patients still experience movement issues even with current DBS treatment. Researchers from the University of California, San Francisco have found that adaptive deep brain stimulation using artificial intelligence can reduce the time a person experiences their most bothersome Parkinson’s symptoms by 50%.
In a recent study published in Nature Medicine, researchers conducted a clinical trial with four participants with Parkinson’s disease already undergoing conventional DBS treatment. They found that adaptive DBS using AI was able to alleviate participants’ most bothersome symptoms by 50% compared to standard DBS. The adaptive DBS continuously monitors brain signals to track a patient’s symptoms and adjusts stimulation intensity in real-time. This allows the device to deliver the correct amount of stimulation needed to control symptoms effectively.
The study showed that adaptive DBS not only reduced the time spent with bothersome motor symptoms but also improved patients’ quality of life. The researchers also monitored various other motor and non-motor symptoms and found that adaptive DBS was not different compared to conventional DBS, and in some cases, even improved other symptoms. Each adaptive DBS algorithm was individualized to address each patient’s most bothersome symptoms, leading to an increase in their quality of life. The findings of the study were considered ground-breaking and have potential implications for improving the care of Parkinson’s patients.
Experts such as Jean-Philippe Langevin, MD, and Shabbar F. Danish, MD, believe that adaptive DBS represents significant progress in the field and a substantial step forward in the care of Parkinson’s patients. Despite the lack of a cure for Parkinson’s disease, advancements in treatments like adaptive DBS can help control symptoms and improve patients’ quality of life. Further research and larger sample sizes are needed to fully understand the impact and potential of adaptive DBS in managing Parkinson’s disease symptoms. With continued refinement of treatments, there is hope for better control and management of Parkinson’s symptoms in the future.
